Herbalife Stock Price, News & Analysis

Herbalife (NYSE:HLF), a health and wellness company, has scheduled its third quarter 2025 financial results announcement for November 5, 2025, after NYSE market close.

The company will host an audio webcast and conference call at 5:30 p.m. ET (2:30 p.m. PT) on the same day, where senior management will discuss the financial results. Participants can access the webcast directly or join via conference call by registering for dial-in information. The earnings release, supplemental materials, and a 12-month replay will be available on Herbalife's investor relations website.

Herbalife (NYSE:HLF), a health and wellness company, announced that CEO Stephan Gratziani and CFO John DeSimone will participate in a fireside chat at the Barclays Global Consumer Staples Conference on September 2, 2025 at 4:30 p.m. ET.

The presentation will be accessible through a live webcast on Herbalife's investor relations website, with a replay available for six months after the event.

Herbalife (NYSE:HLF) reported Q2 2025 financial results with net sales of $1.3 billion, down 1.7% year-over-year but near guidance midpoint. The company's adjusted EBITDA reached $173.6 million, exceeding guidance, while adjusted diluted EPS was $0.59.

Key developments include the launch of MultiBurn™, a new weight-loss supplement, and the beta release of the Pro2col™ digital platform, with over 7,000 distributors joining the early access phase. The company has raised its full-year 2025 guidance for net sales and adjusted EBITDA, now projecting net sales growth between -1.0% to +3.0% YoY and adjusted EBITDA of $640-660 million.

Herbalife (NYSE:HLF) has launched MultiBurn™, a new science-backed weight loss supplement targeting metabolic health. The product features three key botanical ingredients: Morosil™ from Moro blood oranges for weight and circumference reduction, Metabolaid® (hibiscus and lemon verbena) for fat reduction and satiety, and Capsifen™ (red chili pepper and fenugreek) for energy expenditure.

The supplement is designed for daily use with three capsules taken with breakfast or lunch. MultiBurn™ is vegan, gluten-free, and made without synthetic colors or dyes. The product is currently available in the United States, with a planned launch in Puerto Rico in September 2025.

Herbalife (NYSE: HLF), a health and wellness company, has scheduled its second quarter 2025 financial results announcement for Wednesday, August 6, 2025, after NYSE trading hours. The company will host an audio webcast and conference call at 5:30 p.m. ET (2:30 p.m. PT) to discuss the results.

Interested participants can access the webcast through the provided link, while those joining via conference call need to register separately to obtain dial-in information. The earnings release, supplemental materials, and webcast will be accessible through Herbalife's investor relations website, with a replay available for 12 months following the event.

Herbalife (NYSE: HLF) has been recognized as one of U.S. News & World Report's 2025-2026 Best Companies to Work For. The company earned recognition in three categories: Overall Best Companies, Consumer Products Industry, and West Region.

The evaluation, which assessed over 5,000 publicly traded companies, focused on six key factors including pay and benefits, work-life balance, job stability, comfort, belonging, and career opportunities. Herbalife, with approximately 8,600 employees and 2.1 million independent distributors, maintains its position as the #1 active and lifestyle nutrition brand globally for five consecutive years and offers the world's #1 protein shake.

Herbalife (NYSE: HLF) has achieved a significant milestone as AOAC INTERNATIONAL officially certified its proprietary method for identifying and measuring anthraquinones (aloins) in aloe vera. This makes Herbalife's approach the world's first AOAC-approved method for aloin detection, setting new industry standards for botanical quality and safety. The method, developed by Herbalife scientists and validated through a global multi-laboratory study involving eight independent labs, uses HPLC technology to measure aloin A, aloin B, and aloe-emodin. Herbalife employs advanced proton NMR spectrometry for molecular-level verification and implements this testing method across all its aloe-based products sold in over 90 markets. The company's commitment to aloe vera research has resulted in five patents and three published studies, with the testing method now published in the Journal of AOAC INTERNATIONAL.

Herbalife (NYSE: HLF), a health and wellness company, announced that Chief Financial Officer John DeSimone will participate in a fireside chat at the MicroCap Rodeo Conference on June 4, 2025 at 9:30 a.m. ET. The event will be accessible via webcast, with a replay available for six months on Herbalife's investor relations website. The conference will take place in New York City.

Herbalife reported Q1 2025 results with net sales of $1.2 billion, down 3.4% year-over-year but showing 1.4% growth on a constant currency basis. The company achieved adjusted EBITDA of $164.9 million, exceeding guidance, with margin improving 260 basis points versus Q1 2024.

Key highlights include:

• Net income of $50.4 million with adjusted net income of $59.9 million
• Diluted EPS of $0.49; adjusted diluted EPS of $0.59
• Total leverage ratio reduced to 3.0x
• 16% year-over-year growth in new distributors worldwide

The company completed strategic acquisitions of Pro2col Health and Pruvit assets, while forming HBL Link Bioscience with 51% ownership. These moves strengthen Herbalife's position in personalized nutrition and ketone supplements. The company updated its full-year 2025 guidance, narrowing net sales range and raising adjusted EBITDA expectations while reducing capital expenditure forecasts.